{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:40:04Z","timestamp":1770990004567,"version":"3.50.1"},"reference-count":18,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Laryngorhinootologie"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1055\/a-2150-2670","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T23:36:35Z","timestamp":1707262595000},"page":"135-149","source":"Crossref","is-referenced-by-count":1,"title":["Speicheldr\u00fcsentumoren: Limitationen der internationalen Guidelines und Bearbeitungsstand der AWMF-S3-Leitlinie"],"prefix":"10.1055","volume":"103","author":[{"given":"Benedicta","family":"Beck-Broichsitter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Heiland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9671-0784","authenticated-orcid":false,"given":"Orlando","family":"Guntinas-Lichius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"ref3","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/1097-0142(197106)27:63.0.co;2-x","article-title":"Salivary gland tumors in the parotid gland, submandibular gland, and the palate region","volume":"27","author":"CM Eneroth","year":"1971","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.bjoms.2012.10.002","article-title":"Incidence of salivary gland neoplasms in a defined UK population","volume":"51","author":"PJ Bradley","year":"2013","journal-title":"Br J Oral Maxillofac Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2018.00039","article-title":"Contemporary Management of Benign and Malignant Parotid Tumors","volume":"5","author":"J Thielker","year":"2018","journal-title":"Front Surg"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/(SICI)1097-0142(19990501)85:9<2057::AID-CNCR24>3.0.CO;2-F","article-title":"The development of a prognostic score for patients with parotid carcinoma","volume":"85","author":"PV Vander","year":"1999","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00432-015-1961-y","article-title":"Incidence, treatment, and outcome of parotid carcinoma, 1996\u20132011: a population-based study in Thuringia, Germany","volume":"141","author":"O Guntinas-Lichius","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00292-017-0407-5","article-title":"WHO-Klassifikation 2017: Neues zu Tumoren der Speicheldr\u00fcsen","volume":"39","author":"S Ihrler","year":"2018","journal-title":"Der Pathologe"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/hed.27307","article-title":"A molecular guide to systemic therapy in salivary gland carcinoma","volume":"45","author":"AN Weaver","year":"2023","journal-title":"Head Neck"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1107134","DOI":"10.3389\/fonc.2023.1107134","article-title":"Targeted treatment in a case series of AR+, HRAS\/PIK3CA co-mutated salivary duct carcinoma","volume":"13","author":"DT Rieke","year":"2023","journal-title":"Frontiers in oncology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.21.00449","article-title":"Management of Salivary Gland Malignancy: ASCO Guideline","volume":"39","author":"JL Geiger","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1017\/S0022215116000566","article-title":"Management of Salivary Gland Tumours: United Kingdom National Multidisciplinary Guidelines","volume":"130","author":"S Sood","year":"2016","journal-title":"The Journal of laryngology and otology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"100602","DOI":"10.1016\/j.esmoop.2022.100602","article-title":"Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"7","author":"C van Herpen","year":"2022","journal-title":"ESMO Open"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijrobp.2004.03.018","article-title":"The role of radiotherapy in the treatment of malignant salivary gland tumors","volume":"61","author":"CH Terhaard","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/hed.20279","article-title":"Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)","volume":"27","author":"J Bernier","year":"2005","journal-title":"Head Neck"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1200\/JCO.2019.37.15_suppl.6083","article-title":"NISCAHN: A phase II, multicenter nonrandomized trial aiming at evaluating nivolumab (N) in two cohorts of patients (pts) with recurrent\/metastatic (R\/M) salivary gland carcinoma of the head and neck (SGCHN), on behalf of the Unicancer Head & Neck Group","volume":"37","author":"J Fayette","year":"2019","journal-title":"J Clin Oncol"},{"issue":"11","key":"ref18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1055\/a-1792-2246","article-title":"Novel therapeutic approaches for salivary gland carcinomas","volume":"101","author":"L Nachtsheim","year":"2022","journal-title":"Laryngorrhinootologie"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/hed.26541","article-title":"Prognostic role of intraparotid lymph node metastasis in primary parotid cancer: Systematic review","volume":"43","author":"O Guntinas-Lichius","year":"2021","journal-title":"Head Neck"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.nic.2018.01.009","article-title":"State-of-the-Art Imaging of Salivary Gland Tumors","volume":"28","author":"AAK Abdel Razek","year":"2018","journal-title":"Neuroimaging Clin N Am"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133319","article-title":"The Role of an MRI-Based Radiomic Signature in Predicting Malignancy of Parotid Gland Tumors","volume":"15","author":"DD Muntean","year":"2023","journal-title":"Cancers"}],"container-title":["Laryngo-Rhino-Otologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2150-2670.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:58:39Z","timestamp":1730807919000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2150-2670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":18,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2024,2,6]]},"published-print":{"date-parts":[[2024,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2150-2670","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0935-8943","1438-8685"],"issn-type":[{"value":"0935-8943","type":"print"},{"value":"1438-8685","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}